Literature DB >> 20519055

First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate.

Goetz Christoph Mueller1, Ali Dodge-Khatami, Jochen Weil.   

Abstract

Paclitaxel-eluting balloons are a new and innovative method in the treatment of in-stent stenosis and small vessel disease in adult cardiac pathology. The treatment of congenital pulmonary vein stenosis is difficult to manage, and results in a high mortality rate due to residual or recurrent stenosis. We report the first case of treatment for neonatal pulmonary vein restenosis with a paclitaxel-eluting balloon.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519055     DOI: 10.1017/S1047951110000703

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  2 in total

1.  Serum levels after everolimus-stent implantation and paclitaxel-balloon angioplasty in an infant with recurrent pulmonary vein obstruction after repaired total anomalous pulmonary venous connection.

Authors:  Matthias J Müller; Ulrich Krause; Thomas Paul; Heike E Schneider
Journal:  Pediatr Cardiol       Date:  2011-07-28       Impact factor: 1.655

2.  Severe midaortic syndrome: a stepwise approach to treatment with drug-eluting balloons: a case report.

Authors:  Peter Zartner; Christopher Hart; Martin B E Schneider
Journal:  Eur Heart J Case Rep       Date:  2019-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.